LIDOCAINE HYDROCHLORIDE, KETOROLAC TROMETHAMINE (Acunistat-30) Nursing Considerations

What is the generic name?

LIDOCAINE HYDROCHLORIDE, KETOROLAC TROMETHAMINE

What is the Trade Name for LIDOCAINE HYDROCHLORIDE, KETOROLAC TROMETHAMINE?

Acunistat-30

What is the purpose for LIDOCAINE HYDROCHLORIDE, KETOROLAC TROMETHAMINE?

• Purpose First Aid Antiseptic

What are the Indications for LIDOCAINE HYDROCHLORIDE, KETOROLAC TROMETHAMINE?

• INDICATIONS AND USAGE Lidocaine Hydrochloride Injection, USP is indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed.
• INDICATIONS AND USAGE Carefully consider the potential benefits and risks of ketorolac tromethamine and other treatment options before deciding to use ketorolac. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). Acute Pain in Adult Patients Ketorolac tromethamine is indicated for the short-term (‚â§5 days) management of moderately severe acute pain that requires analgesia at the opioid level, usually in a postoperative setting. Therapy should always be initiated with IV or IM dosing of ketorolac tromethamine, and oral ketorolac tromethamine is to be used only as continuation treatment, if necessary. The total combined duration of use of ketorolac tromethamine injection, and oral ketorolac tromethamine is not to exceed 5 days of use because of the potential of increasing the frequency and severity of adverse reactions associated with the recommended doses (see WARNINGS , PRECAUTIONS , DOSAGE AND ADMINISTRATION , and ADVERSE REACTIONS ). Patients should be switched to alternative analgesics as soon as possible, but ketorolac tromethamine therapy is not to exceed 5 days (see DOSAGE AND ADMINISTRATION, Pharmaceutical Information for Ketorolac Tromethamine Injection ) .
• Use For preparation of the skin prior to an injection

References: https://open.fda.gov/